Does IMRT affect thinking and memory in nasopharyngeal cancer patients?
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks at how a precise type of radiation therapy (called IMRT) for nasopharyngeal cancer might affect your thinking and memory over time. It helps doctors understand if any changes happen and how to best support you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with nasopharyngeal cancer (cancer in the back of your nose/throat) and haven't had any treatment yet.
- Your cancer is at an early to moderately advanced stage (Stage I to IVa) and has not spread to other parts of the body.
- You are Han Chinese, right-handed, and between 18 and 60 years old with at least a junior high school education.
- You have no history of head injury, mental illness, or other serious health problems like diabetes or high blood pressure.
- A pre-treatment MRI shows no abnormal spots in the hippocampus (a key memory area of the brain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a newer, more precise type of radiation (proton therapy) works better than standard radiation (IMRT) for people with advanced nasopharyngeal cancer. It also includes chemotherapy and immunotherapy to see if the combination can improve outcomes.
This trial tests whether a smaller radiation treatment area is as effective as the usual larger one for people whose metastatic nasopharyngeal cancer has responded well to first-line chemotherapy plus immunotherapy. It aims to reduce side effects while keeping the cancer under control.
This trial tests a more precise form of radiation therapy (adaptive radiotherapy) for nasopharyngeal cancer. It is designed for patients who have not yet had any treatment and whose cancer is limited to the head and neck area.
This trial tests whether intense radiation therapy (IMRT) alone is effective for people with stage IB nasopharyngeal carcinoma (a type of head and neck cancer) that has not spread to lower lymph nodes or formed large, matted nodes. If you qualify, you would receive targeted radiation without chemotherapy.
This trial compares two types of radiation therapy (IMRT or IMPT plus CIRT) to see which works better for patients with nasopharyngeal cancer that hasn't spread. It's for people who have not had radiation to the head or neck before.
This trial tests if lowering the radiation dose and area for the neck can be as effective as standard treatment for nasopharyngeal cancer. It aims to reduce side effects while still controlling the disease.
Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.